BlackRock Institutional Trust’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$16.1M Buy
721,064
+38,104
+6% +$745K ﹤0.01% 2122
2016
Q3
$12.7M Buy
682,960
+10,390
+2% +$196K ﹤0.01% 2190
2016
Q2
$11M Sell
672,570
-23,616
-3% -$347K ﹤0.01% 2238
2016
Q1
$8.13M Buy
696,186
+18,415
+3% +$206K ﹤0.01% 2395
2015
Q4
$7.92M Sell
677,771
-74,478
-10% -$942K ﹤0.01% 2477
2015
Q3
$9.21M Sell
752,249
-213,518
-22% -$2.72M ﹤0.01% 2351
2015
Q2
$9.11M Buy
965,767
+94,605
+11% +$875K ﹤0.01% 2467
2015
Q1
$7.71M Buy
871,162
+4,554
+0.5% +$46K ﹤0.01% 2550
2014
Q4
$8.69M Sell
866,608
-28,773
-3% -$247K ﹤0.01% 2442
2014
Q3
$6.01M Buy
895,381
+38,730
+5% +$272K ﹤0.01% 2605
2014
Q2
$6.14M Buy
856,651
+225,602
+36% +$1.8M ﹤0.01% 2682
2014
Q1
$6.37M Buy
631,049
+13,935
+2% +$128K ﹤0.01% 2680
2013
Q4
$4.9M Buy
617,114
+53,185
+9% +$496K ﹤0.01% 2795
2013
Q3
$5.59M Sell
563,929
-99,695
-15% -$785K ﹤0.01% 2678
2013
Q2
$3.92M Buy
+663,624
New +$2.23M ﹤0.01% 2810

Other funds holding BEAT

BlackRock Institutional Trust's BEAT Position: Q4 2016 in Review

BlackRock Institutional Trust increased its BioTelemetry, Inc. (BEAT) stake by 5.6% in Q4 2016, buying an estimated $745K and bringing the position to 721,064 shares worth $16.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2122.

BlackRock Institutional Trust first reported a position in BEAT in Q2 2013 and has held it in 15 quarters since. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

  • BlackRock Institutional Trust held 721,064 shares of BioTelemetry, Inc. worth $16.1M as of Q4 2016.
  • BlackRock Institutional Trust bought 38,104 BioTelemetry, Inc. shares in Q4 2016, an estimated $745K.
  • BioTelemetry, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2122 holding.
  • BlackRock Institutional Trust first reported a position in BioTelemetry, Inc. in Q2 2013 and has held it in 15 quarters since.
  • 160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.